InspireMD (NYSE:NSPR) and Longview Acquisition Corp. II (NYSE:LGV) Head to Head Contrast
InspireMD (NYSE:NSPR) and Longview Acquisition Corp. II (NYSE:LGV) Head to Head Contrast
InspireMD (NYSE:NSPR – Get Rating) and Longview Acquisition Corp. II (NYSE:LGV – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.
InspireMD（纽约证券交易所代码：NSPR — 获取评级）和Longview Acquisition Corp. II（纽约证券交易所代码：LGV — 获取评级）都是小型医疗公司，但哪种投资更好？我们将根据两家企业的收益、盈利能力、风险、分析师建议、股息、估值和机构所有权进行比较。
Analyst Ratings
分析师评级
This is a breakdown of current ratings and target prices for InspireMD and Longview Acquisition Corp. II, as provided by MarketBeat.
这是MarketBeat提供的InspireMD和Longview Acquisition Corp. II的当前评级和目标价格的明细。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| InspireMD | 0 | 0 | 0 | 0 | N/A |
| Longview Acquisition Corp. II | 0 | 0 | 0 | 0 | N/A |
| 卖出评级 | 保持收视率 | 买入评级 | 强劲的买入评级 | 评分分数 | |
| InspireMD | 0 | 0 | 0 | 0 | 不适用 |
| Longview 收购二公司 | 0 | 0 | 0 | 0 | 不适用 |
Profitability
盈利能力
This table compares InspireMD and Longview Acquisition Corp. II's net margins, return on equity and return on assets.
该表比较了InspireMD和Longview Acquisition Corp. II的净利润率、股本回报率和资产回报率。
| Net Margins | Return on Equity | Return on Assets | |
| InspireMD | -321.14% | -64.03% | -52.30% |
| Longview Acquisition Corp. II | N/A | -65.52% | 3.65% |
| 净利润 | 股本回报率 | 资产回报率 | |
| InspireMD | -321.14% | -64.03% | -52.30% |
| Longview 收购二公司 | 不适用 | -65.52% | 3.65% |
Institutional & Insider Ownership
机构所有权和内部所有权
1.3% of InspireMD shares are owned by institutional investors. Comparatively, 66.3% of Longview Acquisition Corp. II shares are owned by institutional investors. 3.8% of InspireMD shares are owned by insiders. Comparatively, 26.4% of Longview Acquisition Corp. II shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
InspireMD的1.3％股票由机构投资者持有。相比之下，Longview Acquisition Corp. II中有66.3％的股份由机构投资者持有。InspireMD的股份中有3.8％由内部人士持有。相比之下，Longview Acquisition Corp. II中有26.4％的股份由内部人士强大的机构所有权表明，大型基金经理、捐赠基金和对冲基金认为股票有望实现长期增长。
Risk and Volatility
风险和波动性
InspireMD has a beta of 1.13, meaning that its stock price is 13% more volatile than the S&P 500. Comparatively, Longview Acquisition Corp. II has a beta of 0.04, meaning that its stock price is 96% less volatile than the S&P 500.
InspireMD的beta值为1.13，这意味着其股价的波动性比标准普尔500指数高13％。相比之下，Longview Acquisition Corp. II的beta值为0.04，这意味着其股价的波动性比标准普尔500指数低96％。
Valuation & Earnings
估值与收益
This table compares InspireMD and Longview Acquisition Corp. II's revenue, earnings per share (EPS) and valuation.
该表比较了InspireMD和Longview Acquisition Corp. II的收入、每股收益（EPS）和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| InspireMD | $4.49 million | 2.41 | -$14.92 million | ($2.27) | -0.57 |
| Longview Acquisition Corp. II | N/A | N/A | $7.40 million | N/A | N/A |
| 总收入 | 价格/销售比率 | 净收入 | 每股收益 | 市盈率 | |
| InspireMD | 449 万美元 | 2.41 | -1492 万美元 | (2.27 美元) | -0.57 |
| Longview 收购二公司 | 不适用 | 不适用 | 740 万美元 | 不适用 | 不适用 |
Longview Acquisition Corp. II has lower revenue, but higher earnings than InspireMD.
Longview Acquisition Corp. II的收入较低，但收益却高于Inspire
Summary
摘要
Longview Acquisition Corp. II beats InspireMD on 5 of the 8 factors compared between the two stocks.
与两只股票相比，Longview Acquisition Corp. II在8个因素中有5个超过了InspireMD。
About InspireMD
关于 InspireMD
(Get Rating)
（获取评分）
InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.
InspireMD, Inc. 是一家医疗器械公司，从事其用于治疗复杂血管和冠状动脉疾病的专有microNet支架平台技术的开发和商业化。其产品主要用于急性冠状动脉综合征患者，尤其是急性心肌梗塞和隐静脉移植冠状动脉介入治疗。该公司成立于 2005 年，总部位于以色列特拉维夫。
About Longview Acquisition Corp. II
关于 Longview 收购公司 II
(Get Rating)
（获取评分）
Longview Acquisition Corp. II does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on businesses in the healthcare, industrials, consumer, media, technology, and technology services sector. The company was incorporated in 2020 and is based in New York, New York.
Longview Acquisition Corp. II 没有大规模它打算与一个或多个企业进行合并、资本证券交换、资产收购、股票购买、重组或类似的业务合并。该公司打算专注于医疗保健、工业、消费、媒体、科技和技术服务领域的业务。该公司成立于 2020 年，总部位于纽约州纽约。
Receive News & Ratings for InspireMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InspireMD and related companies with MarketBeat.com's FREE daily email newsletter.
每天接收 InspireMD 的新闻和评级 -在下面输入您的电子邮件地址，即可通过Marketbeat.com的免费每日电子邮件时事通讯接收InspireMD及相关公司的最新新闻和分析师评级的简明每日摘要。